Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| XOMA Corp. | 6 | 0 | 3 | 0 | €21.80 | €68.78 | 215.501% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €69.50 | €69.00 | -0.719% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €39.79 | €70.00 | 75.924% |
| Boston Scientific | 46 | 0 | 10 | 0 | €67.50 | €73.05 | 8.218% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €74.50 | €75.94 | 1.928% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €71.00 | €79.00 | 11.268% |
| Henry Schein Inc. | 12 | 1 | 1 | 0 | €68.46 | €79.48 | 16.095% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €71.36 | €80.00 | 12.108% |
| Centene Corp. | 15 | 0 | 3 | 0 | €71.53 | €82.57 | 15.435% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €70.00 | €84.52 | 20.744% |
| Cytokinetics Inc. | 26 | 1 | 3 | 0 | €55.00 | €84.57 | 53.767% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.40 | €84.74 | 120.688% |
| Bruker Corp. | 7 | 1 | 0 | 0 | €70.84 | €85.68 | 20.955% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.32 | €86.77 | 39.235% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €74.50 | €86.90 | 16.640% |
| Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €79.20 | €88.14 | 11.285% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €89.00 | €92.26 | 3.663% |
| Haemonetics Corp. | 8 | 0 | 1 | 0 | €88.50 | €98.31 | 11.081% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €70.16 | €100.00 | 42.531% |
| Viking Therapeutics Inc | 5 | 0 | 2 | 0 | €66.74 | €100.00 | 49.835% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.16 | €102.62 | 34.741% |
| Addus Homecare Corp. | 15 | 1 | 4 | 1 | €97.00 | €103.07 | 6.258% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €65.00 | €106.18 | 63.353% |